Characterisation of the cellular changes induced by ultraviolet A radiation
Characterisation of the cellular changes induced by ultraviolet A radiation
批准号:
nhmrc : 302021
负责人:
A/Pr Scott Byrne
金额:
$29.91万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2006-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Sunlight is an important environmental health hazard as it causes immunosuppression and cancer. It suppresses our ability to destroy developing cancers. Australia has the highest incidence of skin cancer in the world, 66% of Australians develop skin cancer during their lifetime. The relationship between UV dose, wavelength and cancer in humans is unknown. As this cannot be directly experimentally determined in humans, surrogate biological endpoints such as immunosuppression will help determine the damaging wavebands within sunlight. There has been little work on the effect of UVA on health or the mechanisms of action of UVA compared to UVB. A recent consensus UVA working group of 80 international participants convened by the American Academy of Dermatology out of concern about the lack of knowledge of UVA on human health concluded that the action spectrum for photocarcinogenesis and photoageing, particularly the efficacy of UVA in humans remains to be elucidated, and that more funding should be provided for radiation biology research to help elucidate UVA mechanisms of injury. Similarly a recent expert meeting (including Prof. Halliday) convened by the International Agency for Research on Cancer (WHO) on sunscreen protection from skin cancer recommended that studies should be conducted on the effects of exposure to UVA in causing both photoageing and skin cancer which followed from their major recommendation that it is important to understand the nature of the dose-response relationship on risk and the action spectrum for each effect . The studies described in this project will contribute to these recommendations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dendritic Cells in Ultraviolet Radiation-Induced Immunosuppression and Skin Tumour Regression
-
批准号:nhmrc : 307726
-
项目类别:Early Career Fellowships
-
资助金额:$18.49万
-
财政年份:2004
-
负责人:A/Pr Scott Byrne
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
-
批准号:82371144
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汪雪玲
-
依托单位:
长寿基因SIRT7调控核苷酸切除修复通路的机制研究
-
批准号:32100605
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:耿安珂
-
依托单位:
溶酶体蛋白LAPTM4B通过与Xc-系统相互作用调控谷胱甘肽代谢的机制研究
-
批准号:32100623
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周可成
-
依托单位:
小鼠肺分支早期发育中肺上皮单细胞的时-空转录组的建立与分析
-
批准号:32070795
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:蔡军
-
依托单位:
乳腺癌上皮间质转化中核苷酸代谢相关的功能蛋白发现和机理研究
-
批准号:32070748
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2020
-
负责人:戴凌云
-
依托单位:
rhTβ4增强间充质干细胞调节T细胞代谢重塑治疗干眼的机制研究
-
批准号:32000530
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:陈小鸟
-
依托单位:
胰岛素和细菌信号协同调节巨噬细胞免疫反应的作用
-
批准号:92057105
-
项目类别:重大研究计划
-
资助金额:89.0万元
-
批准年份:2020
-
负责人:Tiffany Shy Yea Horng
-
依托单位:
一种全新的高尔基体胆固醇感应蛋白的鉴定和功能研究
-
批准号:32070755
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:钟辉
-
依托单位:
葡萄糖调节的AXIN溶酶体膜转运的分子机制
-
批准号:32070753
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2020
-
负责人:李梦琪
-
依托单位:
胞浆甘氨酰-tRNA合成酶cytoGARS感知甘氨酸的分子机制及其对肝细胞癌的影响
-
批准号:32070756
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2020
-
负责人:汪维
-
依托单位: